{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:45:42Z","timestamp":1764053142810},"reference-count":86,"publisher":"American Chemical Society (ACS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Res. Toxicol."],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1021\/tx600275d","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T18:29:18Z","timestamp":1170440958000},"page":"300-310","source":"Crossref","is-referenced-by-count":8,"title":["DNA Adduct Formation in the Livers of Female Sprague\u2212Dawley Rats Treated with Toremifene or \u03b1-Hydroxytoremifene"],"prefix":"10.1021","volume":"20","author":[{"given":"Gon\u00e7alo","family":"Gamboa da Costa","sequence":"first","affiliation":[{"name":"Centro de Qu\u00edmica Estrutural, Complexo I, Instituto Superior T\u00e9cnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal, and Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079"}]},{"given":"Pedro C.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Centro de Qu\u00edmica Estrutural, Complexo I, Instituto Superior T\u00e9cnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal, and Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079"}]},{"given":"Mona I.","family":"Churchwell","sequence":"additional","affiliation":[{"name":"Centro de Qu\u00edmica Estrutural, Complexo I, Instituto Superior T\u00e9cnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal, and Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079"}]},{"given":"Frederick A.","family":"Beland","sequence":"additional","affiliation":[{"name":"Centro de Qu\u00edmica Estrutural, Complexo I, Instituto Superior T\u00e9cnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal, and Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079"}]},{"given":"M. Matilde","family":"Marques","sequence":"additional","affiliation":[{"name":"Centro de Qu\u00edmica Estrutural, Complexo I, Instituto Superior T\u00e9cnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal, and Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079"}]}],"member":"316","published-online":{"date-parts":[[2007,1,30]]},"reference":[{"key":"tx600275db00001\/tx600275db00001_1","volume-title":"Tamoxifen for early breast cancer:\u2009 an overview of the randomised trials. Lancet 351, 1451\u22121467","author":"Early Breast Cancer Trialists' Collaborative Group.","year":"1998"},{"key":"tx600275db00002\/tx600275db00002_1","volume-title":"Tamoxifen for breast cancer among hysterectomised women. Lancet 359, 1122\u22121124","author":"Veronesi U.","year":"2002"},{"key":"tx600275db00003\/tx600275db00003_1","volume-title":"First results from the International Breast Cancer Intervention Study (IBIS-I):\u2009 a randomised prevention trial. Lancet 360, 817\u2212824","author":"Investigators","year":"2002"},{"key":"tx600275db00004\/tx600275db00004_1","volume-title":"Overview of the main outcomes in breast-cancer prevention trials. Lancet 361, 296\u2212300","author":"Cuzick J.","year":"2003"},{"key":"tx600275db00005\/tx600275db00005_1","first-page":"1662","volume":"97","author":"Fisher B.","journal-title":"J. Natl. Cancer Inst."},{"key":"tx600275db00006\/tx600275db00006_1","first-page":"651","volume":"87","author":"Rutqvist L. E.","journal-title":"J. Natl. Cancer Inst."},{"key":"tx600275db00007\/tx600275db00007_1","first-page":"330","volume":"76","author":"Mignotte H.","journal-title":"Int. J. Cancer"},{"key":"tx600275db00008\/tx600275db00008_1","first-page":"1662","volume":"91","author":"Bernstein L.","journal-title":"J. Natl. Cancer Inst."},{"key":"tx600275db00009\/tx600275db00009_1","volume-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet 356, 881\u2212887","author":"Bergman L.","year":"2000"},{"key":"tx600275db00010\/tx600275db00010_1","first-page":"947","volume":"18","author":"Braithwaite R. S.","journal-title":"J. Gen. Intern. Med."},{"key":"tx600275db00011\/tx600275db00011_1","first-page":"384","volume":"97","author":"Swerdlow A. J.","journal-title":"J. Natl. Cancer Inst."},{"key":"tx600275db00012\/tx600275db00012_1","volume-title":"Understanding the genotoxicity of tamoxifen? Carcinogenesis 22, 839\u2212849","author":"Phillips D. H.","year":"2001"},{"key":"tx600275db00013\/tx600275db00013_1","volume-title":"Tamoxifen activation of the estrogen receptor\/AP-1 pathway:\u2009 potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9, 443\u2212456","author":"Webb P.","year":"1995"},{"key":"tx600275db00014\/tx600275db00014_1","volume-title":"ICI 182,780 inhibits endogenous estrogen-dependent rat uterine growth and tamoxifen-induced developmental toxicity. Biol. Reprod. 54, 160\u2212167","author":"Branham W. S.","year":"1996"},{"key":"tx600275db00015\/tx600275db00015_1","first-page":"137","volume":"176","author":"Schwartz L. B.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"tx600275db00016\/tx600275db00016_1","volume-title":"Modulation of endometrial steroid receptors and growth regulatory genes by tamoxifen. Obstet. Gynecol. 95, 697\u2212703","author":"Elkas J.","year":"2000"},{"key":"tx600275db00017\/tx600275db00017_1","first-page":"S46","volume":"36","author":"Karck U.","journal-title":"Eur. J. Cancer"},{"key":"tx600275db00018\/tx600275db00018_1","volume-title":"Tamoxifen-associated malignant endometrial tumors:\u2009 pathologic features and expression of hormone receptors estrogen-\u03b1, estrogen-\u03b2 and progesterone","author":"Wilder J. L.","year":"2004"},{"key":"tx600275db00019\/tx600275db00019_1","first-page":"2095","volume":"59","author":"Terashima I.","year":"2091","journal-title":"Cancer Res."},{"key":"tx600275db00020\/tx600275db00020_1","volume-title":"Comparison between the effects of tamoxifen and toremifene on the uterus in postmenopausal breast cancer patients. Gynecol. Oncol. 59, 261\u2212266","author":"Tom\u00e1s E.","year":"1995"},{"key":"tx600275db00021\/tx600275db00021_1","volume-title":"Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancer. Drugs 54, 141\u2212160","author":"Wiseman L. R.","year":"1997"},{"key":"tx600275db00022\/tx600275db00022_1","first-page":"1162","volume":"83","author":"Marttunen M. B.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"tx600275db00023\/tx600275db00023_1","first-page":"S62","volume":"36","author":"M\u00e4enp\u00e4\u00e4 J.","journal-title":"Eur. J. Cancer"},{"key":"tx600275db00024\/tx600275db00024_1","volume-title":"Toremifene:\u2009 an evaluation of its safety profile. The Breast 15, 142\u2212157","author":"Harvey H. A.","year":"2006"},{"key":"tx600275db00025\/tx600275db00025_1","first-page":"2566","volume":"13","author":"Hayes D. F.","journal-title":"J. Clin. Oncol."},{"key":"tx600275db00026\/tx600275db00026_1","volume-title":"A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Breast Cancer Res. Treat. 45, 251\u2212262","author":"Gershanovich M.","year":"1997"},{"key":"tx600275db00027\/tx600275db00027_1","first-page":"277","volume":"76","author":"Pyrh\u00f6nen S.","journal-title":"Br. J. Cancer"},{"key":"tx600275db00028\/tx600275db00028_1","volume-title":"Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer. Breast Cancer Res. Treat. 56, 133\u2212143","author":"Pyrh\u00f6nen S.","year":"1999"},{"key":"tx600275db00029\/tx600275db00029_1","first-page":"3494","volume":"18","author":"Holli K.","journal-title":"J. Clin. Oncol."},{"key":"tx600275db00030\/tx600275db00030_1","first-page":"S38","volume":"38","author":"Holli K","journal-title":"Eur. J. Cancer"},{"key":"tx600275db00031\/tx600275db00031_1","volume-title":"Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer. Breast Cancer Res. Treat. 65, 119\u2212124","author":"Milla-Santos A.","year":"2001"},{"key":"tx600275db00032\/tx600275db00032_1","doi-asserted-by":"crossref","unstructured":"Pagani, O., Gelber, S., Simoncini, E., Castiglione-Gertsch, M., Price, K., Zahrieh, D., Gelber, R., Coates, A., and Goldhirsch, A., International Breast Cancer Study Group. (2004) Toremifene and tamoxifen are equally effective for early-stage breast cancer:\u2009 first results of International Breast Cancer Study Group Trials 12-93 and 14-93.Ann. Oncol.15, 1749\u22121759.","DOI":"10.1093\/annonc\/mdh463"},{"key":"tx600275db00033\/tx600275db00033_1","first-page":"971","volume":"176","author":"Price D.","journal-title":"J. Urol."},{"key":"tx600275db00034\/tx600275db00034_1","first-page":"215","volume":"36","author":"Sipil\u00e4 H.","journal-title":"J. Steroid Biochem."},{"key":"tx600275db00035\/tx600275db00035_1","first-page":"252","volume":"36","author":"Anttila M.","journal-title":"J. Steroid Biochem."},{"key":"tx600275db00036\/tx600275db00036_1","first-page":"1895","volume":"47","author":"Berthou F.","year":"1883","journal-title":"Biochem. Pharmacol."},{"key":"tx600275db00037\/tx600275db00037_1","volume-title":"Toremifene metabolism in rat, mouse and human liver microsomes:\u2009 Identification of \u03b1-hydroxytoremifene by LC-MS. Biomed. Chromatogr. 16, 361\u2212363","author":"Jones R. M.","year":"2002"},{"key":"tx600275db00038\/tx600275db00038_1","volume-title":"\u03b1-Hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes. Chem. Res. Toxicol. 16, 1138\u22121144","author":"Kim S. Y.","year":"2003"},{"key":"tx600275db00039\/tx600275db00039_1","volume-title":"DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver. Cancer Sci. 97, 468\u2212477","author":"Hashiba M.","year":"2006"},{"key":"tx600275db00040\/tx600275db00040_1","volume-title":"Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res. 53, 4534\u22124541","author":"Hard G. C.","year":"1993"},{"key":"tx600275db00041\/tx600275db00041_1","volume-title":"Tamoxifen induces hepatocellular carcinoma in rat liver:\u2009 a 1-year study with two antiestrogens. Arch. Toxicol. 67, 49\u221254","author":"Hirsim\u00e4ki P.","year":"1993"},{"key":"tx600275db00042\/tx600275db00042_1","volume-title":"A two-year dietary carcinogenicity study of the antiestrogen toremifene in Sprague-Dawley rats. Drug Chem. Toxicol. 19, 245\u2212266","author":"Karlsson S.","year":"1996"},{"key":"tx600275db00043\/tx600275db00043_1","volume-title":"Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver. Carcinogenesis 18, 2247\u22122253","author":"Williams G. M.","year":"1997"},{"key":"tx600275db00044\/tx600275db00044_1","volume-title":"Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis. Arch. Toxicol. 74, 249\u2212256","author":"K\u00e4rki A.","year":"2000"},{"key":"tx600275db00045\/tx600275db00045_1","volume-title":"Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats. Carcinogenesis 16, 2733\u22122741","author":"Dragan Y. P.","year":"1995"},{"key":"tx600275db00046\/tx600275db00046_1","volume-title":"Genotoxicity studies with the antiestrogen toremifene. Drug Chem. Toxicol. 21, 449\u2212476","author":"Williams G. M.","year":"1998"},{"key":"tx600275db00047\/tx600275db00047_1","volume-title":"Tamoxifen causes gene mutations in the livers of lambda\/lacI transgenic rats. Cancer Res. 57, 1288\u22121293","author":"Davies R.","year":"1997"},{"key":"tx600275db00048\/tx600275db00048_1","volume-title":"DBA\/2 and C57BL\/6 mice and in human MCL-5 cells. Carcinogenesis 13, 2197\u22122203.","author":"White I. N. H.","year":"1992"},{"key":"tx600275db00049\/tx600275db00049_1","volume-title":"Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver. Arch. Toxicol. 68, 272\u2212275","author":"Montandon F.","year":"1994"},{"key":"tx600275db00050\/tx600275db00050_1","doi-asserted-by":"crossref","unstructured":"Hemminki, K., Widlak, P., and Hou, S.M. (1995) DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytesin vitro.Carcinogenesis16, 1661\u22121664.","DOI":"10.1093\/carcin\/16.7.1661"},{"key":"tx600275db00051\/tx600275db00051_1","volume-title":"Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus. Cancer Res. 57, 1438\u22121441","author":"Li D.","year":"1997"},{"key":"tx600275db00052\/tx600275db00052_1","volume-title":"Comparisons of the binding of [14C]radiolabelled tamoxifen or toremifene to rat DNA using accelerator mass spectrometry. Chem.-Biol. Interact. 106, 149\u2212160","author":"White I. N. H.","year":"1997"},{"key":"tx600275db00053\/tx600275db00053_1","volume-title":"DNA adduct formation by tamoxifen and structurally-related compounds in rat liver. Chem.-Biol. Interact. 113, 145\u2212159","author":"Rajaniemi H.","year":"1998"},{"key":"tx600275db00054\/tx600275db00054_1","volume-title":"Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene. Breast Cancer Res. Treat. 60, 63\u221270","author":"Hellmann-Blumberg U.","year":"2000"},{"key":"tx600275db00055\/tx600275db00055_1","volume-title":"Antiestrogens and the formation of DNA damage in rats:\u2009 a comparison. Chem. Res. Toxicol. 19, 852\u2212858","author":"Kim S. Y.","year":"2006"},{"key":"tx600275db00056\/tx600275db00056_1","volume-title":"Mechanism of lower genotoxicity of toremifene compared with tamoxifen. Cancer Res. 61, 3925\u22123931","author":"Shibutani S.","year":"2001"},{"key":"tx600275db00057\/tx600275db00057_1","first-page":"391","volume-title":"3rd. ed.","author":"Perrin D. D.","year":"1988"},{"key":"tx600275db00058\/tx600275db00058_1","volume-title":"N-hydroxy-N\u2018-acetylbenzidine and 1-nitrosopyrene. Mutagenesis 1, 201\u2212206.","author":"Heflich R. H.","year":"1986"},{"key":"tx600275db00059\/tx600275db00059_1","doi-asserted-by":"crossref","unstructured":"Gamboa da Costa, G., Marques, M. M., Beland, F. A., Freeman, J. P., Churchwell, M. I., and Doerge, D. R. (2003) Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.Chem. Res. Toxicol.16, 357\u2212366.","DOI":"10.1021\/tx020090g"},{"key":"tx600275db00060\/tx600275db00060_1","volume-title":"Hybridization of nuclear matrix attached deoxyribonucleic acid fragments. Biochemistry 20, 6921\u22126929","author":"Basler J.","year":"1981"},{"key":"tx600275db00061\/tx600275db00061_1","first-page":"131","volume":"308","author":"Beland F. A.","journal-title":"J. Chromatogr."},{"key":"tx600275db00062\/tx600275db00062_1","volume-title":"Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7, 1543\u22121551","author":"Reddy M. V.","year":"1986"},{"key":"tx600275db00063\/tx600275db00063_1","volume-title":"DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives. Carcinogenesis 22, 1307\u22121315","author":"Gamboa da Costa G.","year":"2001"},{"key":"tx600275db00064\/tx600275db00064_1","first-page":"1497","volume":"28","author":"Foster A. B.","journal-title":"J. Med. Chem."},{"key":"tx600275db00065\/tx600275db00065_1","volume-title":"Identification of tamoxifen-DNA adducts formed by \u03b1-sulfate tamoxifen and \u03b1-acetoxytamoxifen. Chem. Res. Toxicol. 10, 189\u2212196","author":"Dasaradhi L.","year":"1997"},{"key":"tx600275db00066\/tx600275db00066_1","volume-title":"Characterization of the major DNA adduct formed by \u03b1-hydroxy-N-desmethyltamoxifen in vitro and in vivo. Chem. Res. Toxicol. 13, 200\u2212207","author":"Gamboa da Costa G.","year":"2000"},{"key":"tx600275db00067\/tx600275db00067_1","doi-asserted-by":"crossref","unstructured":"Gamboa da Costa, G., Marques, M. M., Freeman, J. P., and Beland, F. A. (2003) Synthesis and investigation of \u03b1-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen. Chem. Res. Toxicol.16, 1090\u22121098.","DOI":"10.1021\/tx030010o"},{"key":"tx600275db00068\/tx600275db00068_1","first-page":"2992","volume":"5","author":"Tessier P. E.","journal-title":"Org. Lett."},{"key":"tx600275db00069\/tx600275db00069_1","volume-title":"Preparation and identification of cis and trans isomers of a substituted triarylethylene. Nature 212, 733\u2212734","author":"Bedford G. R.","year":"1966"},{"key":"tx600275db00070\/tx600275db00070_1","first-page":"1547","volume":"65","author":"Richardson A., Jr.","journal-title":"J. Pharm. Sci."},{"key":"tx600275db00071\/tx600275db00071_1","volume-title":"Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen. Cancer Res. 56, 66\u221271","author":"Osborne M. R.","year":"1996"},{"key":"tx600275db00072\/tx600275db00072_1","volume-title":"Minor products of reaction of DNA with \u03b1-acetoxytamoxifen. Carcinogenesis 18, 539\u2212543","author":"Osborne M. R.","year":"1997"},{"key":"tx600275db00073\/tx600275db00073_1","volume-title":"Identification of tamoxifen-DNA adducts induced by \u03b1-acetoxy-N-desmethyltamoxifen. Chem. Res. Toxicol. 13, 761\u2212769","author":"Kitagawa M.","year":"2000"},{"key":"tx600275db00074\/tx600275db00074_1","first-page":"1954","volume":"18","author":"Marques M. M.","year":"1949","journal-title":"Carcinogenesis"},{"key":"tx600275db00075\/tx600275db00075_1","doi-asserted-by":"crossref","unstructured":"Kuramochi, H. (1996) Conformational studies and electronic structures of tamoxifen and toremifene and their allylic carbocations proposed 310 as reactive intermediates leading to DNA adduct formation.J. Med. Chem.39, 2877\u22122886.","DOI":"10.1021\/jm960255g"},{"key":"tx600275db00076\/tx600275db00076_1","volume-title":"Absence of DNA adduct in the leukocytes from breast cancer patients treated with toremifene. Chem. Res. Toxicol. 19, 421\u2212425","author":"Umemoto A.","year":"2006"},{"key":"tx600275db00077\/tx600275db00077_1","doi-asserted-by":"crossref","unstructured":"Bartsch, H., Phillips, D. H., Nair, J., Hewer, A., Meyberg-Solomeyer, G., and Grischke, E.M. (2000) Lack of evidence for tamoxifen- and toremifene-DNA adducts in lymphocytes of treated patients.Carcinogenesis21, 845\u2212847.","DOI":"10.1093\/carcin\/21.4.845"},{"key":"tx600275db00078\/tx600275db00078_1","volume-title":"Letter to the editor","author":"Beland F. A.","year":"2005"},{"key":"tx600275db00079\/tx600275db00079_1","volume-title":"Letter to the editor","author":"Shibutani S.","year":"2005"},{"key":"tx600275db00080\/tx600275db00080_1","first-page":"341","volume":"100","author":"Pukkala E.","journal-title":"Int. J. Cancer"},{"key":"tx600275db00081\/tx600275db00081_1","first-page":"1558","volume":"90","author":"O'Regan R. M.","journal-title":"J. Natl. Cancer Inst."},{"key":"tx600275db00082\/tx600275db00082_1","first-page":"902","volume":"84","author":"Marttunen M. B.","journal-title":"Br. J. Cancer"},{"key":"tx600275db00083\/tx600275db00083_1","first-page":"1897","volume":"98","author":"Hachisuga T.","year":"1890","journal-title":"Cancer"},{"key":"tx600275db00084\/tx600275db00084_1","first-page":"1103","volume":"92","author":"Hachisuga T.","journal-title":"Br. J. Cancer"},{"key":"tx600275db00085\/tx600275db00085_1","volume-title":"Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene. Cancer Chemother. Pharmacol. 55, 343\u2212346","author":"Wall\u00e9n M.","year":"2005"},{"key":"tx600275dn00001\/tx600275dn00001_1","volume-title":"Ac, acetyl","author":"Abbreviations"}],"container-title":["Chemical Research in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/tx600275d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:50:57Z","timestamp":1678881057000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/tx600275d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,30]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2,1]]}},"alternative-id":["10.1021\/tx600275d"],"URL":"https:\/\/doi.org\/10.1021\/tx600275d","relation":{},"ISSN":["0893-228X","1520-5010"],"issn-type":[{"value":"0893-228X","type":"print"},{"value":"1520-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,30]]}}}